By Yasin Ebrahim
Investing.com - AztraZeneca moved off session lows Thursday after the European Medical Agency's safety committee found the company's vaccine to be “safe and effective in preventing Covid-19, and its benefits outweigh its risk."
The health watchdog said the benefits of using AstraZeneca's vaccine outweigh the potential risks, and recommended that countries proceed with vaccinations.
AstraZeneca PLC ADR (NASDAQ:AZN) dipped 0.57%, to $49.79.
The positive news on the vaccine front comes just as the reopening gathers pace. The White House is looking to relax restrictions on travel across the borders with Mexico and Canada and on inbound international travel from the U.K., Europe and Brazil, toward the middle of May, CNBC reported, citing two sources familiar with the matter.